-
Goldfinch Bio Aims $55M and Cancer Strategy at Genetic Kidney Disease
Dec 14, 2016, 09:35 AM by Michael CroftXconomy | Chronic kidney disease affects more than 10 percent of U.S. adults, and the risk of developing the condition increases with age. New biotech Goldfinch Bio wants to turn genetic research into new therapies.Full story -
Recipharm bolsters development business with new appointments in the US and Europe
Dec 14, 2016, 09:23 AM by Michael CroftSTOCKHOLM, SWEDEN - Dec 14, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has appointed Anders Högdin and Aaron Small to lead the growth of its pharmaceutical development services business in the US and EuropeFull story -
2017 Biotech Predictions Foretell Race Towards Cloud, e-Commerce and Greater Transparency
Dec 13, 2016, 18:19 PM by Michael CroftPALO ALTO, CA - Dec 13, 2016 - Bioz, Inc., developers of the worlds first search engine for life science experimentation, today highlighted six predictions for how the biotechnology industry will make strides in 2017 to advance health and drug discoveryFull story -
New Funds for ONT, Self-Sequencing Challenge from Clive Brown
Dec 13, 2016, 12:00 PM by Michael CroftBio-IT World Oxford Nanopore Technologies yesterday announced $126 million in new funding through a private placement of ordinary shares. The investment round was led by new investor GT Healthcare, a pan-Asian fund with special reach in China, and existing investor Woodford Investment Management on behalf of its clients. Clive Brown, Oxford Nanopore's CTO, also released the "Cliveome" yesterday, his own self-sequenced genome.Full story -
Kerafast Celebrates 5 Years of Facilitating Access to Research Reagents
Dec 13, 2016, 10:05 AM by Michael CroftBOSTON, MA, UNITED STATES - Dec 13, 2016 - Kerafast Inc., developers of an industry-leading online platform to facilitate accessibility to unique bioresearch materials from laboratories across the globe, is celebrating its five-year anniversary this DecemberFull story -
Complexities Of Consent
Dec 13, 2016, 09:47 AM by Michael CroftClinical Informatics News | As genomics continues to grow and evolve, the need to find a balance between scientific progress and patient protection is as great as ever.Full story -
CRISPR Tech Heralds Hype, Hope, and Hurdles for Gene-Based Therapeutics
Dec 12, 2016, 10:30 AM by Michael CroftFull storyBio-IT World | The age of CRISPR has heralded in new lines of business based on cutting-edge, gene-editing technologies. Here are a few of the highlights of CRISPR's impact on the industry.
-
First US Exascale Supercomputer Now On Track for 2021
Dec 12, 2016, 09:40 AM by Michael CroftTop500 | The US Department of Energy's Exascale Computing Project (ECP) has changed its timeline for getting the first post-petascale system into the field. The new goal is to get an initial exascale system deployed sometime in 2021, with acceptance nine months after that. That shrinks the schedule significantly and puts the country back on a more competitive trajectory with regard to China and Japan.Full story -
BOC Sciences Launched Inhibitors for Alzheimer’s Diseases Studies
Dec 12, 2016, 04:53 AM by Michael CroftLONG ISLAND CITY, NY, UNITED STATES - Dec 12, 2016 - BOC Sciences launched inhibitors in accordance with Research areas. At present, there are three domains covered-cancer Immunotherapy, hsp90, alzheimer's diseaseFull story -
DNAnexus Reanalyzes Cancer Genome Atlas Data
Dec 9, 2016, 17:50 PM by Michael CroftBio-IT World Brief | DNAnexus announced today that it has performed uniform reanalysis and mutation calling on the world’s largest pan-cancer dataset, encompassing 10,487 patients across 33 cancer types from The Cancer Genome Atlas (TCGA). The mutation data has undergone additional quality control and filtering and is available as an open access dataset for download at the NCI Genomic Data Commons and on Synapse. The pipelines used are also fully available to researchers who wish to reproduce this TCGA mutation discovery via DNAnexus or a GitHub repository.Full story -
Francis Collins says he would remain NIH director under Trump
Dec 9, 2016, 16:13 PM by Michael CroftSTAT | The director of the NIH said Friday that it would be a "privilege" to remain in that post if asked to stay by President-elect Donald Trump.Full story -
Controversial Impact Factor Gets a Heavyweight Rival
Dec 8, 2016, 11:11 AM by Michael CroftNature News & Comment | On December 8, Elsevier launched the CiteScore Index, a new way to assess the quality of academic journals. Elsevier's CiteScore uses a larger database - and provides different results than the Journal Impact Factor.Full story -
Infectious Disease Testing Dominates the Ancillary Hospital Location Diagnostic Testing due to High Prevalence Rate of the Infectious Diseases
Dec 8, 2016, 06:49 AM by Michael CroftALBANY,, NY, UNITED STATES - Dec 8, 2016 - Ancillary hospital location includes those support locations other than board, room, medical and nursing services that are offered to the patients during their course of careFull story -
Radioactive Diagnostic Agent Market is Witnessing Stiff Competition among Existing Radioactive Diagnostics Agent Manufacturers
Dec 8, 2016, 02:35 AM by Michael CroftALBANY,, NY, UNITED STATES - Dec 8, 2016 - Radioactive agents are the nucleus of an unstable atom which emits radiations such as alpha, beta, gamma and X-rays and loses its energyFull story -
United States Positive End Expiratory Pressure (PEEP) Valve Industry Opportunity
Dec 8, 2016, 01:54 AM by Michael CroftSAN FRANCISCO, CA, UNITED STATES - Dec 8, 2016 - United States Positive End Expiratory Pressure (PEEP) Valve Industry 2016 Market Research Report analysed the current state in the definitions, classifications, applications and industry chain structureFull story -
Big Data Holds Key to Life Saving Discoveries Says Biomatters Whitepaper
Dec 7, 2016, 17:48 PM by Michael CroftAUCKLAND, NEW ZEALAND - Dec 8, 2016 - A whitepaper released today by bioinformatics technology company Biomatters examines the critical role big data will play in enabling scientists to discover life saving biologic drugs of the futureFull story -
Biotech Trial of the Century Could Determine Who Owns CRISPR
Dec 7, 2016, 13:33 PM by Michael CroftMIT Technology Review | Attorneys in a dispute over CRISPR gene-editing make their case to patent judges.Full story -
Biotech Has A Solution For The Clean Water Crisis
Dec 7, 2016, 10:42 AM by Michael CroftForbes | As peak oil fears fade, water has emerged as the next resource crisis. The solution comes from drug development biotechnologies honed by the pharmaceutical industry.Full story -
CRISPR Hearing Puts University of California on the Defensive
Dec 7, 2016, 10:27 AM by Michael CroftSTAT | The University of California has a steep hill to climb if it wants to overturn the 2014 decision awarding key CRISPR patents to the Broad Institute.Full story -
Elucigene partners with Congenica on new NGS cystic fibrosis kit
Dec 7, 2016, 05:22 AM by Michael CroftCAMBRIDGE, UK - Dec 7, 2016 - The emergence of new therapies that treat the causes of cystic fibrosis is creating an imperative for more accurate variant analysisFull story